查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1138318

全球单核细胞增多症诊断市场 - 2022-2029

Global Mononucleosis Diagnostic Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球传染性单核细胞增多症诊断市场受到传染性单核细胞增多症 (IM) 发病率上升、对单核细胞增多症的认识和了解增加、IM 治疗研发活动增加等因素的推动。由于增加等因素，市场正在增长。

对传染性单核细胞增多症的调查，提高对单核细胞增多症的认识和认识，以及增加对单核细胞增多症治疗的研究和开发，预计将推动市场增长。

传染性单核细胞增多症 (IM) 发病率的上升，对单核细胞增多症的认识和认识的不断提高，以及对 IM 诊断和治疗的研究和开发活动的增加，正在促进全球单核细胞增多症诊断。这是扩大单核细胞增多症的主要原因。

此外，还有各种新技术进步可以比市场上已有的技术更快地诊断感染。例如，2020 年罗氏宣布美国 FDA 批准 Cobas EBV 检测，这是美国第一个用于诊断 EBV Epstein-Barr 病毒的定量体外诊断检测。这对医疗保健行业和专业人士来说是一个巨大的成功，因为可以在更短的时间内完成更多的测试，从而更容易监测有感染这种病毒风险的患者。

全球青少年人口的增长也是导致市场增长的主要因素之一，因为单核细胞增多症是青少年和成人中最常见的疾病。我来了。世界上一半以上的青少年生活在亚洲。南亚有近 3.5 亿青少年，比其他任何地区都多。紧随其后的是拥有 3 亿多人口的东亚和太平洋地区。这些地区的青年人口比世界其他任何地方都要少。世界卫生组织 (WHO) 报告称，世界上有近 12 亿青少年（10-19 岁）。在一些国家，预计到 2050 年青少年人数将增加，主要是在低收入和中等收入国家 (LMIC)，青少年占人口的四分之一，近 90% 的 10 至 19 岁儿童生活在这些国家。

用于诊断单核细胞增多症的现有测试的局限性预计会阻碍市场增长。

单核细胞增多症诊断测试□□存在一些局限性，预计将阻碍预测期内的市场增长。只有三个测试可以诊断单核细胞增多症，考虑到传染性单核细胞增多症的增长率，这是非常低的。

行业分析

全球单核细胞增多症诊断市场根据波特五力分析、监管分析、供应链分析、产品创新和未满足需求等各种行业因素对市场进行深入分析。

全球单核细胞增多症诊断市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页内容。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 传染性单核细胞增多症 (IM) 发病率的上升和对单核细胞增多症的认识不断提高
    • 限制因素
      • 抑制因素：现有检测单核细胞增多症的局限性
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 产品创新
  • 未满足的需求

第 6 章按测试类型

  • 爱泼斯坦-巴尔病毒 (EBV) 抗体检测
  • 单点测试
  • 完整的血细胞计数测试

第 7 章，最终用户

  • 医院
  • 实验室
  • 其他

第 8 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 9 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 测试类型基准测试
  • 值得关注的重点公司列表

第 10 章公司简介

  • Bio-Rad Laboratories Inc.
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Thermo Fischer Scientific Inc.
  • Abbott Laboratories
  • Cardinal Health Inc.
  • Arlington Scientific Inc.
  • Quidel Corporation
  • Beckman Coulter Inc.
  • Immunostics Inc.
  • Meridian Bioscience
  • Sekisui Diagnostics

第11章 全球单核细胞增多症诊断市场-DataM

简介目录
Product Code: DMPH2195

Market Overview

The Global mononucleosis diagnostic market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.9 % during the forecast period (2022-2029).

Mono, or mononucleosis, is an acute infectious disease caused by the Epstein-Barr virus (EBV). People with mononucleosis often have a high fever, Laryngitis, hepatosplenomegaly, abnormal lymphocyte, and others. Most cases of mono are mild and can be treated easily. Adolescents and young adults (12 to 40 years old) are more likely to be affected. There are various detection tests used for the diagnosis of mononucleosis such as the complete blood count test, monospot test, and Epstein Barr virus (EBV) antibody test.

Market Dynamics

The global mononucleosis diagnostic market is growing owing to several factors including rising incidence of infectious mononucleosis (IM), growing rising awareness and knowledge about mononucleosis, and increasing research & development activities for IM treatment.

Rising incidence of infectious mononucleosis (IM), growing rising awareness and knowledge about mononucleosis, and increasing research & development activities for IM treatment are expected to drive market growth.

The rising incidence of infectious mononucleosis (IM), growing rising awareness and knowledge about mononucleosis, and increasing research & development activities for IM diagnosis and treatment are the major factors that are increasing the global mononucleosis diagnostic market.

Various novel technological advancements are taking place that can diagnose the infection faster as compared to already present in the market. For instance, in 2020, Roche announced that the USFDA has approved the Cobas EBV test that is the 1st in-vitro quantitative diagnostic test in US for the diagnosis of EBV Epstein-Barr Virus. This is very huge success for the healthcare industry and professionals as now it will be easy to monitor the patients at risk from this virus as it will conduct high number of tests in small duration of time.

Increasing adolescent population globally is also one of the major factors leading to growth of the market as mononucleosis is most common among teens and adults. More than half of all adolescents globally live in Asia. South Asia has nearly 350 million adolescents than any other region. It is followed by East Asia and the Pacific with over 300 million. The adolescent population of either of these regions are dwarfs that of any other region in the world. According to World Health Organization (WHO) report, there are nearly 1.2 billion adolescents (10-19 years old) worldwide. In some countries, adolescents account for a quarter of the population and the number of adolescents is expected to rise through 2050, mainly in low- and middle-income countries (LMICs) where close to 90% of 10- to 19-year-olds live.

Limitations of available tests for the diagnosis of mononucleosis is expected to hamper the market growth.

There are some limitations associated with mononucleosis diagnostic tests which are expected to hamper the market's growth over the forecast period. There are only three tests that can diagnose mononucleosis and that is very low in regard to the rate by which the infectious mononucleosis is growing.

Industry Analysis

The global mononucleosis diagnostic market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces Analysis, Regulatory Analysis, Supply Chain Analysis, Product Innovations, Unmet Needs

Segment Analysis

Monospot Test segment is expected to hold the largest market share in global mononucleosis diagnostic market

On the basis of test type, the mononucleosis diagnsotic market is segmented into Epstein Barr Virus (EBV) antibody test, monospot test, and complete blood count test. Among these, the monospot test segment accounted for the largest market share, owing to the several benefits associated with this test, such as accurate results, non-interference with other tests, cost-effectiveness, rapid detection of antibodies, among others. A monospot test is a quick screening test to detect a type of antibody (heterophil antibody) that forms during certain infections. This test is also used in the detection of other diseases with similar symptoms, such as cytomegalovirus infection, HIV, and strep throat. In this test, a blood sample is placed on a microscope slide and mixed with other substances. If heterophil antibodies are present, then the blood clumps (agglutinates), and indicates a mono infection. Monospot testing can usually detect antibodies 2 to 9 weeks after a person is infected. It typically is not used to diagnose mono that started more than 6 months earlier. Also, increase in awareness and knowledge regarding the disease are expected to drive the growth of this segment over the forecast period.

Geographical Analysis

North America region holds the largest market share in the global mononucleosis diagnostic market

North America is dominating the global mononucleosis diagnostic market, and is expected to hold the highest market share over the forecast period, owing to rising incidence rate of infectious mononucleosis (IM), advancement in healthcare infrastructure supporting novel testing, and increasing research and development activities by major players in this region. Majority of the younger people in United States are infected with mononucleosis. According to the United States Census Bureau, there were 41,910,114 people aged between 10-19 in the United States, which is approx. 13% of the total population. Hence, with rising adolescent population this region, the market of mononucleosis diagnostic is growing rapidly.

On the other hand, the Asia-Pacific mononucleosis diagnostic market is growing at the fastest growth rate over the forecast period, owing to the rising adolescent population in this region. According to the UNICEF data, over half of all adolescents across the world live in Asia, and South Asia is home to the largest number of adolescents in any region in the world (around 340 million). South Asia is followed by East Asia and the Pacific, with around 277 million. Hence, due to increasing number of adolescents, huge opportunities are estimated to drive the growth of the market during the forecast period.

Competitive Landscape

The global mononucleosis diagnostic market is highly competitive with presence of smaller and major players. Some of the major players in the market include: Bio-Rad Laboratories Inc., Thermo Fischer Scientific Inc., Abbott Laboratories, Cardinal Health Inc., Arlington Scientific Inc., Quidel Corporation, Beckman Coulter Inc., Immunostics Inc., Meridian Bioscience, Sekisui Diagnostics, among others.

The key players are adopting various growth strategies such as Test Type launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the mononucleosis diagnostic market globally. For instance, in September 2019, Roche launched two tests, for use on the automated cobas 6800/8800 Systems in countries accepting the CE mark. The cobas EBV (Epstein-Barr virus) and cobas BKV (BK virus) Tests provide reliable, standardized, high-quality results for clinical decision-making to help manage the risk of infection and improve the management of severely immunocompromised transplant patients.

In July 2019, NeuMoDx Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, launched CE-IVD assays for Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV), which can cause infectious mononucleosis and other illnesses.

Key Companies to Watch

Bio-Rad Laboratories

Overview: Bio-Rad Laboratories is an American company that develops and manufactures various products with technological advancements for Clinical Diagnostics and Life Science research. It was founded in 1952 and is headquartered in Berkeley, California. This company operates worldwide.

Product Portfolio: PLATELIA™ EB-NA-1 IgG: This product is used for the detection of IgG and IgM antibodies that are specific to the EBV antigen. Platelia EBV EIA microplate technology is widely used for detection of infectious mononucleosis.

Key Developments: In Mar 2021, Bio-Rad Laboratory revealed its partnership with F. Hoffmann-La Roche AG

The global mononucleosis diagnostic market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising incidence of infectious mononucleosis (IM) and Growing awareness towards mononucleosis
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations of Available Tests for the Diagnosis of Mononucleosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Product Innovations
  • 5.5 Unmet Needs

6. By Test Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 6.1.2. Market Attractiveness Index, By Test Type Segment
  • 6.2. Epstein Barr Virus (EBV) Antibody Test
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Monospot Test
  • 6.4. Complete Blood Count Test

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User Segment
  • 7.2. Hospitals
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Laboratories
  • 7.4. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.5.1. Germany
      • 8.3.5.2. U.K.
      • 8.3.5.3. France
      • 8.3.5.4. Italy
      • 8.3.5.5. Spain
      • 8.3.5.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.5.1. Brazil
      • 8.4.5.2. Argentina
      • 8.4.5.3. Rest of South America
  • 8.5. Asia Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.5.1. China
      • 8.5.5.2. India
      • 8.5.5.3. Japan
      • 8.5.5.4. Australia
      • 8.5.5.5. Rest of Asia Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Key Developments and Strategies
  • 9.2. Company Share Analysis
  • 9.3. Test Types Benchmarking
  • 9.4. List of Key Companies to Watch

10. Company Profiles

  • 10.1 Bio-Rad Laboratories Inc.*
    • 10.1.1 Company Overview
    • 10.1.2 Product Portfolio and Description
    • 10.1.3 Key Highlights
    • 10.1.4 Financial Overview
  • 10.2 Thermo Fischer Scientific Inc.
  • 10.3 Abbott Laboratories
  • 10.4 Cardinal Health Inc.
  • 10.5 Arlington Scientific Inc.
  • 10.6 Quidel Corporation
  • 10.7 Beckman Coulter Inc.
  • 10.8 Immunostics Inc.
  • 10.9 Meridian Bioscience
  • 10.10 Sekisui Diagnostics

LIST NOT EXHAUSTIVE

11. Global Mononucleosis Diagnostic Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Distribution Channel
  • 11.3. Contact Us